Re: RE: NONMEM 7 Update
I do have only one simple question. How many people took advantage from the
fact Nonmem was distributed as open source? If we are talking about a very
small percentage, is this discussion worthwhile? How many people except bob
bauer and may be somebody else I am not aware of are able to follow and
understand the cuirrent nonmem code?
Serge
Quoted reply history
________________________________
From: [email protected]
To: Ludden, Thomas ; [email protected]
Sent: Thu Jul 02 23:46:09 2009
Subject: [NMusers] RE: NONMEM 7 Update
Thomas
Didn't ICON consider that indeed, this decision might stimulate the divergence
of an open-source clade of NONMEM, somewhat like R stemmed out of S-plus? If a
small academic group starts to work in that direction, it would certainly be
quickly joined by many…
Thierry Buclin
Univ. Hospital, Lausanne
De : [email protected] [mailto:[email protected]] De la
part de Ludden, Thomas
Envoyé : jeudi, 2. juillet 2009 15:15
À : Eleveld, DJ; [email protected]
Cc : Krohn, Anthony
Objet : RE: [NMusers] NONMEM 7 Update
Dear All:
Icon Development Solutions has invested in the further development of
NONMEM. By mutual agreement with the University of California at San
Francisco, NONMEM 7 is intellectual property belonging to IDS. However, IDS
will continue to pay royalties to UCSF.
The business plan under which NONMEM 7 was developed calls for the
protection of the I.P. involved. In addition, NONMEM 7 contains several
updated routines developed and owned by IMSL (Visual Numerics Inc.). Our
agreement with IMSL stipulates that we will not distribute their source code.
The installer will compile the software but will not allow the unencrypted
source code to remain on the users computer. The licensing agreement will also
stipulate that any attempt to access the source code will be a violation of the
agreement.
Some source code will be left unencrypted for various reasons, one
being the need for users to change certain values in SIZES and perhaps other
resource routines.
Tom
Thomas M. Ludden Ph.D.
Vice-President, Pharmacometrics R&D
ICON Development Solutions
Tel: + 1 410 696 3040
Mob: + 1 410 258 2411
Fax: + 1 410 480 0776
Email: [email protected]
Web: www.icondevsolutions.com
--
The information contained in this email message may
contain confidential or legally privileged information and is intended solely
for the use of the named recipient(s). No confidentiality or privilege is
waived or lost by any transmission error. If the reader of this message is
not the intended recipient, please immediately delete the e-mail and all
copies of it from your system, destroy any hard copies of it and notify the
sender either by telephone or return e-mail. Any direct or indirect use,
disclosure, distribution, printing, or copying of any part of this message is
prohibited. Any views expressed in this message are those of the individual
sender, except where the message states otherwise and the sender is
authorized to state them to be the views of XOMA.